Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...
There's another theory about the Covid-19 pandemic going around, and while it is pretty cool, it's not exactly the solution ...
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...
BI-1808 and pembrolizumab combination shows a 24% ORR in recurrent ovarian cancer, surpassing pembrolizumab monotherapy's 8% ...
Researchers at Ben-Gurion University of the Negev (BGU) have discovered that a gene long known for shaping the skin’s physical barrier also plays a crucial role in building and maintaining the skin’s ...
The Chosun Ilbo on MSN
Sakaguchi: Cancer becomes ordinary via immunity in 20 years
Once an era arrives where cancer can be treated through immunity, cancer will no longer be a fearsome disease but an ordinary ...
MiNK Therapeutics (Nasdaq: INKT) today announced that new translational data supporting the role of invariant natural killer T (iNKT) cells in idiopathic pulmonary fibrosis (IPF) were presented at the ...
A common cold affects people differently. While some suffer from mild symptoms, for others, it can be life-threatening. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results